In a remarkable case reported from Italy in April 2026, a 76-year-old man named Luigi Stefanelli underwent surgical removal of an abdominal tumor while under hypnosis as the sole anesthetic, describing the experience as mentally tending to his garden—planting seeds, harvesting tomatoes, and preparing sauce—during the procedure. This event, documented by medical staff at Turin’s Molinette Hospital, has reignited scientific discussion about hypnosis as a potential adjunct or alternative to conventional anesthesia in select surgical cases, particularly for elderly or high-risk patients where pharmacological agents pose significant dangers.
Understanding Hypnosis in Surgical Context: Beyond Suggestion
Medical hypnosis, when used in clinical settings, induces a trance-like state characterized by heightened focus, reduced peripheral awareness, and increased responsiveness to therapeutic suggestions. Unlike stage hypnosis, clinical hypnotherapy is a regulated practice grounded in neuroscience, with demonstrated effects on pain perception, anxiety modulation, and autonomic regulation. In surgical applications, it aims not to eliminate sensation entirely but to alter the cognitive and emotional interpretation of pain, thereby reducing distress and physiological stress responses. The mechanism involves top-down cortical regulation of subcortical pain pathways, particularly through decreased activity in the anterior cingulate cortex and insula—brain regions associated with the affective dimension of pain—while sparing sensory-discriminative processing in the somatosensory cortex.
This case is not the first of its kind but represents a growing body of evidence supporting hypnoanesthesia in specific contexts. A 2023 meta-analysis published in The Lancet reviewed 47 randomized controlled trials involving over 3,800 patients and found that hypnosis significantly reduced intraoperative analgesic requirements, postoperative pain scores, nausea, vomiting, and hospital stay duration compared to standard care alone. Notably, benefits were most pronounced in superficial and short-duration procedures, though successful applications have been reported in more complex surgeries, including thyroidectomies, breast cancer operations, and cesarean sections.
In Plain English: The Clinical Takeaway
- Hypnosis does not eliminate pain like general anesthesia but changes how the brain processes discomfort, making it more manageable without drugs.
- We see best suited for motivated patients undergoing shorter, less invasive surgeries and should never replace standard anesthesia without specialist evaluation.
- When combined with local anesthetics, hypnosis can reduce opioid utilize, lower side effects like nausea, and potentially speed recovery—especially in older adults.
Clinical Evidence and Limitations: What the Data Shows
While Luigi Stefanelli’s case is compelling, it is essential to contextualize it within existing research. Hypnosis is not universally effective; susceptibility varies widely among individuals, with approximately 10–15% of the population considered highly hypnotizable, 80% moderately responsive, and 5–10% largely unresponsive. A 2022 NIH-funded study published in JAMA Surgery (N=210) comparing hypnosis plus local anesthesia to general anesthesia for breast cancer surgery found no significant difference in patient-reported pain or satisfaction between groups, but the hypnosis group used 40% less intraoperative fentanyl and reported lower postoperative nausea (18% vs. 42%).
Importantly, hypnosis requires extensive preoperative preparation—often multiple sessions over weeks—to establish rapport and therapeutic efficacy. It is not a last-minute solution. In Stefanelli’s case, reports indicate he had undergone prior hypnotherapy for chronic pain, suggesting a pre-existing level of responsiveness that likely contributed to the outcome.
Geo-Epidemiological Bridging: Integration into European Healthcare Systems
In Italy, hypnotherapy is recognized as a complementary therapy within the national health system (Servizio Sanitario Nazionale) in certain regions, including Piedmont, where Molinette Hospital is located. However, it is not routinely offered as a primary anesthetic in public hospitals due to variability in practitioner training and lack of standardized protocols. The Italian Society of Hypnosis and Psychotherapy (SIPNEI) advocates for greater integration, particularly in geriatric and oncology settings where minimizing pharmacological burden is a priority.
Comparatively, the UK’s NHS has incorporated hypnotherapy into pain management programs since 2006, with NICE guidelines acknowledging its utility for irritable bowel syndrome and preoperative anxiety. In Germany, hypnosis is more widely integrated into surgical practice, especially in university hospitals, supported by reimbursement through statutory health insurance under specific indications. The FDA in the United States does not regulate hypnosis as a device or drug but permits its use as a behavioral intervention when administered by licensed professionals.
Funding, Bias, and Scientific Integrity
The case of Luigi Stefanelli appears to be a clinical observation rather than a formal trial, and no external funding source has been disclosed for this specific instance. However, broader research into hypnoanesthesia has received support from public institutions. For example, a 2021 multicenter trial across France, Belgium, and Switzerland investigating hypnosis for thyroid surgery was funded by the French National Research Agency (ANR) and published in Annals of Surgery. Transparency about funding is critical: industry-sponsored studies on anesthetic alternatives may carry bias toward pharmaceutical outcomes, whereas publicly funded research tends to focus on patient-centered outcomes like recovery quality and psychological well-being.
“Hypnosis in surgery isn’t about replacing the anesthesiologist—it’s about reducing the physiological toll of surgery, especially in frail patients. We’re not seeing miracles; we’re seeing measurable reductions in stress biomarkers and opioid consumption when hypnosis is used correctly.”
— Dr. Elise Moretti, PhD, Lead Researcher in Behavioral Anesthesiology, University of Lyon, INSERM U1028
Comparative Outcomes: Hypnosis vs. Conventional Approaches
| Outcome Measure | Hypnosis + Local Anesthesia | Standard General Anesthesia | Notes |
|---|---|---|---|
| Intraoperative Opioid Use (mg fentanyl equiv.) | 85 ± 22 | 142 ± 31 | Indicate ± SD; *p<0.01* |
| Postoperative Nausea/Vomiting | 22% | 38% | Based on pooled RCT data (n=1,200) |
| Patient Satisfaction (1–10 scale) | 8.7 | 8.4 | No significant difference |
| Recovery Room Time (minutes) | 68 ± 15 | 89 ± 24 | Faster emergence and orientation |
Contraindications & When to Consult a Doctor
Hypnosis for procedural support is not appropriate for everyone. Individuals with untreated psychosis, severe personality disorders, or active substance intoxication should not undergo hypnotherapy due to risk of adverse psychological reactions. Patients with cognitive impairment, dementia, or inability to cooperate (e.g., severe delirium) are also poor candidates. Hypnosis should never be used as the sole anesthetic for major surgeries involving significant tissue trauma, prolonged duration, or hemodynamic instability—such as open-heart surgery, major vascular procedures, or emergency trauma laparotomies—where deep unconsciousness and muscle relaxation are medically necessary.
Patients considering hypnosis as part of their surgical plan should consult with both their surgeon and a licensed clinical hypnotherapist certified by recognized bodies such as the American Society of Clinical Hypnosis (ASCH) or the European Society of Hypnosis (ESH). A preoperative assessment is essential to evaluate hypnotic suitability, manage expectations, and ensure integration with standard medical care. Any increase in pain, anxiety, or distress during the procedure warrants immediate conversion to conventional anesthesia.
Future Outlook: Evidence-Based Integration, Not Sensationalism
The Luigi Stefanelli case underscores a valuable principle in modern medicine: patient-centered care includes exploring non-pharmacological tools that reduce suffering and treatment burden. However, enthusiasm must be tempered by rigor. Hypnosis is not a replacement for evidence-based anesthesia but a potential adjunct in carefully selected cases—particularly for older adults, those with opioid intolerance, or patients seeking to minimize pharmacological exposure.
Future directions include standardized training protocols, objective neurophysiological monitoring (e.g., EEG-based hypnosis depth indicators), and larger pragmatic trials assessing long-term outcomes like chronic postoperative pain and opioid dependence. Until then, cases like Stefanelli’s serve as poignant reminders that the mind’s capacity to modulate experience remains one of medicine’s most underutilized frontiers—not because it is miraculous, but because it is profoundly human.
References
- Jensen MP, et al. Hypnosis for surgical pain control: An updated meta-analysis. The Lancet. 2023;401(10380):987–999.
- Faymonville ME, et al. Hypnosis and sedation vs. General anesthesia for breast cancer surgery: A randomized controlled trial. JAMA Surgery. 2022;157(5):442–450.
- Liossi C, et al. Hypnotherapy for preoperative anxiety: A systematic review and meta-analysis. International Journal of Clinical and Experimental Hypnosis. 2021;69(3):257–278.
- Schnetz A, et al. Hypnosis for thyroid surgery: A multicenter randomized controlled trial. Annals of Surgery. 2021;274(4):612–620.
- Jensen MP, Barber J. Theoretical and clinical approaches to hypnosis for pain control. Pain. 2022;163(4):e456–e465.
